ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,310Medicare Part D Prescriptions Filled, Including Refills

Rank: 228 out of 2429

$551K Total Retail Price of All Prescriptions

Rank: 217 out of 2429

399 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 477 285 1 1
LEVOTHYROXINE SODIUM 377 248 2 3
AMLODIPINE BESYLATE 356 310 3 4
OMEPRAZOLE 346 188 4 7
METOPROLOL TARTRATE 299 263 5 9
FUROSEMIDE 253 182 6 5
LISINOPRIL 250 133 7 2
METFORMIN HCL 247 131 8 8
WARFARIN SODIUM 242 236 9 11
ENALAPRIL MALEATE 228 198 10 32
HYDROCHLOROTHIAZIDE 215 171 11 10
RISPERIDONE 173 21 12 52
POTASSIUM CHLORIDE 150 115 13 14
CITALOPRAM HBR 147 140 14 19
ATORVASTATIN CALCIUM 140 137 15 13
DONEPEZIL HCL 139 139 16 26
HYDROCODONE-ACETAMINOPHEN 138 136 S3 17 6
ALENDRONATE SODIUM 125 35 18 20
PRAVASTATIN SODIUM 124 100 19 16
CLOPIDOGREL 123 111 20 31
LOSARTAN POTASSIUM 122 92 21 22
TAMSULOSIN HCL 117 41 22 29
LOSARTAN-HYDROCHLOROTHIAZIDE 109 80 23 73
GLIMEPIRIDE 106 61 24 51
METOPROLOL SUCCINATE 104 88 25 12
SERTRALINE HCL 100 86 26 23
POLYETHYLENE GLYCOL 3350 99 29 27 56
GABAPENTIN 89 26 28 18
BACLOFEN 85 0 29 143
DIVALPROEX SODIUM 85 0 29 78
LOVASTATIN 81 65 31 30
PLAVIX 81 73 31 44
ZOLPIDEM TARTRATE 79 70 33 28
CRESTOR 77 55 34 25
LEVETIRACETAM 77 29 34 91
OXCARBAZEPINE 72 0 36 183
TRIAMTERENE-HCTZ 68 68 37 53
CELEBREX 62 55 38 97
NAMENDA 62 61 38 35
DIGOXIN 61 56 40 43
DIVALPROEX SODIUM ER 61 0 40 111
CYCLOBENZAPRINE HCL 58 22 R 42 69
ADVAIR DISKUS 58 52 42 49
QUETIAPINE FUMARATE 57 0 44 77
FINASTERIDE 57 21 44 126
SPIRIVA 55 37 46 54
CARVEDILOL 55 36 46 21
FENOFIBRATE 52 19 48 48
LAMOTRIGINE 51 0 49 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.